Cyclipostins, process for their preparation and use thereof
AssigneeAventis Pharma Deutschland GmbH
InventorsLaszlo Vertesy, Klaus Ehrlich, Michael Kurz, Joachim Wink
Life of this patent
Estimating the term…
Loading patent…
AssigneeAventis Pharma Deutschland GmbH
InventorsLaszlo Vertesy, Klaus Ehrlich, Michael Kurz, Joachim Wink
Estimating the term…
The invention relates to compounds of formula I 1 in which R1, R2, E, X1, X2, and X3 have the meaning as described in the specification and claims, obtained by culturing Streptomyces species HAG 004107 (DSM 13381), and their physiologically tolerable salts and chemical equivalents. The invention furthermore relates to a process for the preparation of the cyclipostins, the microorganism HAG 004107 (DSM 13381), the use of the cyclipostins and their physiologically tolerable salts and chemical equivalents as pharmaceuticals, in particular as inhibitors of lipases, and pharmaceutical preparations which contain cyclipostin or a physiologically tolerable salt or equivalent thereof.
A compound of formula I
Isolated Streptomyces species HAG 004107, DSM 13381.
Dependencies are inferred from the claim text.